Case Study: Novo Nordisk accelerates digital health innovation with Vynyl

Novo Nordisk validates 30+ digital health concepts with Vynyl

Novo Nordisk faced the challenge of building digital health capabilities to match their core business excellence. They needed to move beyond isolated ideas and establish a structured approach to prioritize opportunities, validate concepts rapidly, and secure crucial stakeholder buy-in across the organization. They partnered with Vynyl for its strategy and innovation services to systematize their discovery process.

Vynyl implemented a collaborative innovation framework that balanced rapid experimentation with pharmaceutical industry constraints. This approach included intensive design thinking workshops, rapid prototyping, and extensive user research. The results included over 30 product concepts prototyped and validated, a dramatic decrease in validation cycles, and the establishment of research panels that reduced feedback from months to days. Vynyl helped transform Novo Nordisk's innovation culture, establishing a foundation for sustained digital innovation.

Novo Nordisk